German chemical company BASF and the University of California Davis have joined forces to research and develop new features for infant nutrition from indigestible carbohydrates called human milk oligosaccharides (HMOs). Substantial evidence has shown that a high concentration of HMOs in human milk contributed to health advantages associated with breastfeeding and could help the gut microbiome, as well as benefit brain health for infants, children and adults, they said. The four-year-old partnership is part of BASF’s Californian Research Alliance, a two-year collaboration focused on new materials and their applications along with biosciences and related technology.
German chemical company BASF and the University of California Davis have joined forces to research and develop new features for infant nutrition from indigestible carbohydrates called human milk oligosaccharides (HMOs). Substantial evidence has shown that a high concentration of HMOs in human milk contributed to health advantages associated with breastfeeding and could help the gut microbiome, as well as benefit brain health for infants, children and adults, they said. The two-year partnership is part of BASF’s Californian Research Alliance, a four-year-old collaboration focused on new materials and their applications along with biosciences and related technology.